American Century Companies’s AnaptysBio ANAB Stock Holding History

American Century Companies’s Portfolio ANAB Stock Details ANAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-11,012	Closed	-$236K	–	2927
2023 Q4	$236K	Buy	11,012 +159	+1%	+$2.74K	﹤0.01%	2646
2023 Q3	$195K	Buy	+10,853	New	+$207K	﹤0.01%	2601
2019 Q4	–	Sell	-29,933	Closed	-$1.05M	–	1501
2019 Q3	$1.05M	Buy	29,933 +1,841	+7%	+$87.6K	﹤0.01%	1026
2019 Q2	$1.58M	Sell	28,092 -94	-0.3%	-$6.77K	﹤0.01%	1045
2019 Q1	$2.06M	Sell	28,186 -1,340	-5%	-$92.5K	﹤0.01%	988
2018 Q4	$1.88M	Sell	29,526 -829	-3%	-$61.6K	﹤0.01%	983
2018 Q3	$3.03M	Sell	30,355 -241	-0.8%	-$20K	﹤0.01%	957
2018 Q2	$2.17M	Buy	30,596 +8,044	+36%	+$675K	﹤0.01%	1007
2018 Q1	$2.35M	Buy	22,552 +2,322	+11%	+$262K	﹤0.01%	973
2017 Q4	$2.04M	Buy	+20,230	New	+$1.49M	﹤0.01%	1007

Other funds holding ANAB

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

American Century Companies's ANAB Position: Q1 2024 in Review

American Century Companies sold out of AnaptysBio (ANAB) in Q1 2024, closing a stake of 11,012 shares — an estimated $236K sold.

American Century Companies first reported a position in ANAB in Q4 2017 and held it in 10 quarters. The position peaked at $3.03M in Q3 2018. 133 funds tracked by Wall St. Rank hold ANAB as of Q1 2024.

American Century Companies reported no remaining AnaptysBio position as of Q1 2024 after selling out during the quarter.
American Century Companies sold 11,012 AnaptysBio shares in Q1 2024, an estimated $236K.
American Century Companies first reported a position in AnaptysBio in Q4 2017 and held it in 10 quarters.
American Century Companies's AnaptysBio position peaked at $3.03M in Q3 2018.
133 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2024.

Based on American Century Companies's 13F filing for Q1 2024, filed 14 May 2024.